INTECH Investment Management
LUCD icon

INTECH Investment Management’s Lucid Diagnostics LUCD Stock Holding History

INTECH Investment Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-36,526
Closed -$39.1K – 1710
2026
Q2 		$39.1K Buy
36,526
+13,245
+57% +$14.3K ﹤0.01% 2078
2026
Q1 		$26.8K Sell
23,281
-10,697
-31% -$13.6K ﹤0.01% 2056
2025
Q4 		$37K Buy
33,978
+3,889
+13% +$4.35K ﹤0.01% 2282
2025
Q3 		$30.4K Sell
30,089
-6,265
-17% -$6.84K ﹤0.01% 2390
2025
Q2 		$41.8K Buy
+36,354
New +$47K ﹤0.01% 2431

Other funds holding LUCD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

INTECH Investment Management's LUCD Position: Q3 2026 in Review

INTECH Investment Management sold out of Lucid Diagnostics (LUCD) in Q3 2026, closing a stake of 36,526 shares — an estimated $39.1K sold.

INTECH Investment Management first reported a position in LUCD in Q2 2025 and held it in 5 quarters. The position peaked at $41.8K in Q2 2025. 82 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

  • INTECH Investment Management reported no remaining Lucid Diagnostics position as of Q3 2026 after selling out during the quarter.
  • INTECH Investment Management sold 36,526 Lucid Diagnostics shares in Q3 2026, an estimated $39.1K.
  • INTECH Investment Management first reported a position in Lucid Diagnostics in Q2 2025 and held it in 5 quarters.
  • INTECH Investment Management's Lucid Diagnostics position peaked at $41.8K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.